Jump to content

Bianca Weinstock-Guttman

From Wikipedia, the free encyclopedia
Bianca Weinstock-Guttman
Academic background
EducationMD, 1983, University of Bucharest
Academic work
InstitutionsUniversity at Buffalo

Bianca Weinstock-Guttman is an American neurologist. She is a SUNY Distinguished Professor at the University at Buffalo.

Early life and education

[edit]

Weinstock-Guttman completed her medical degree at the University of Bucharest in 1983 and her internship at Meir Hospital and Tel Aviv University.[1]

Career

[edit]

Upon completing her formal education, Weinstock-Guttman accepted a faculty position at University of Buffalo in 1998.[2] In 2006, she helped establish the Pediatric MS Center of Buffalo with a grant from the National Multiple Sclerosis Society.[2] In this role, she received the 2013 UB Exceptional Scholars Sustained Achievement Award.[3]

In 2017, Weinstock-Guttman was named the principal investigator to lead clinical trials exploring potential therapeutic applications of cannabinoids in progressive multiple sclerosis.[4] The following year, she received the National Multiple Sclerosis Society's Impact Award for her research, patient care and advocacy skills.[5] During the COVID-19 pandemic, Weinstock-Guttman co-authored Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient with Dejan Jakimovski.[6] She was also the recipient of the 2020 Stockton Kimball Award for outstanding scientific achievement and service.[7] The following year, she was promoted to the rank of SUNY Distinguished Professor, the highest rank in the SUNY system.[8]

References

[edit]
  1. ^ "Bianca Weinstock-Guttman MD". medicine.buffalo.edu. Retrieved May 7, 2021.
  2. ^ a b Schmitt, Jane (March 21, 2018). "Dr. Weinstock-Guttman fights to make a difference for MS patients". Buffalo Business First. Retrieved May 7, 2021.
  3. ^ "10 Medical School Faculty Honored at UB 'Celebration of Excellence'". medicine.buffalo.edu. October 15, 2013. Retrieved May 8, 2021.
  4. ^ Silva, Patricia (November 14, 2017). "MMJ Hires Lead Investigator for Phase 2 Trials of Medicinal Cannabis to Treat Progressive MS". multiplesclerosisnewstoday.com. Retrieved May 7, 2021.
  5. ^ "Weinstock-Guttman Honored By National Multiple Sclerosis Society". medicine.buffalo.edu. March 21, 2018. Retrieved May 7, 2021.
  6. ^ Jakimovski, Dejan; Weinstock–Guttman, Bianca (September 2021). "Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient". Acta Neurologica Belgica. 122 (2): 565–566. doi:10.1007/s13760-021-01799-8. PMC 8444159. PMID 34529258.
  7. ^ "Noted MS Researcher Wins Stockton Kimball Award". medicine.buffalo.edu. September 29, 2020. Retrieved May 7, 2021.
  8. ^ "Three faculty named SUNY Distinguished Professors". University of Buffalo. May 7, 2021. Retrieved December 26, 2021.
[edit]